Nadine Jahchan, Ph.D.
| Stanford University | # of Grants: 1 |
Grants
| Novel biomarkers and chemoprevention approaches for SCLC | 2012 (Cycle 21) | $127,052 |
| Early Diagnosis/Pathogenesis | Postdoctoral Fellowship Awards | |
Publications
| A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors | ||||
| Periodical: Cancer Discovery | Index Medicus: | |||
| Authors: Jahchan NS, Dudley JT, Mazur PK, Flores N, Yang D, Palmerton A, Zmoos AF, Vaka D, Tran K, | ART | |||
| Yr: 2013 | Vol: 3 | Nbr: 12 | Abs: | Pg: 1364-1377 |
| A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors | ||||
| Periodical: Cancer Discovery | Index Medicus: | |||
| Authors: Jahchan NS, Dudley JT, Mazur PK, Flores N, Yang D, Palmerton A, Zmoos AF, Vaka D, Tran K, | ART | |||
| Yr: 2013 | Vol: 3 | Nbr: 12 | Abs: | Pg: 1364-1377 |